Regulatory mandates and AI-powered dose optimization drive adoption. Hybrid partnerships expand access in emerging markets.

FN Media Group News Commentary - According to reports from industry insiders the Global AI in Diabetic Retinopathy market is projected to continue to grow at a substantial rate for years to come.

Top global virologists publish a comprehensive analysis and advocate for a multi-government initiative in the Lancet Regional Health-Americas< ...

The healthcare landscape as we knew it, like several other industries, has been fundamentally transformed by artificial ...

Targeted protein degradation (TPD) is transforming drug discovery by leveraging the cell’s natural protein disposal systems ...

Nocion Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel small molecule charged sodium channel blockers called "nocions", that selectively affect actively firing ...

Palo Alto Networks® , the global cybersecurity leader, today unveiled Cortex XSIAM® 3.0, the next evolution of its industry-leading SecOps platform, bolstered with proactive exposure management and ...

Artificial intelligence stands as the central force behind how work exists already in the present time.

Gu, Y. and Hou, B. (2025) The Influence of Family Function of Caregivers of Malignant Tumor Patients on Their Positive ...

As the pharmaceutical industry continues to push the boundaries of innovation, the role of digital solutions like eCOA ...

Rather than replacing physicians, technology can help redefine their roles, enabling a more patient-centered, ...

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, that severely impacts motor and non-motor functions. Early detection and effective ...